Spondyloarthropathies Completed Phase 4 Trials for Golimumab (DB06674)

Also known as: Spondyloarthropathy / Spondylarthropathies / Seronegative arthritis (disorder) / Spondylosis (disorder) / Disorder of joint of spine (disorder) / Spondyloarthrosis / Spondyloarthropathy (disorder)

IndicationStatusPhase
DBCOND0027340 (Spondyloarthropathies)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01718951Golimumab Versus Pamidronate for the Treatment of Axial Spondyloarthropathy: a 48-week TrialTreatment